Despite a rapidly growing tumor in his hypopharynx, Nguyen Luong Loi refuses hospitalization and endures severe pain to save every penny for his nine-year-old daughter's chemotherapy.

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...

The FDA is approving a generic drug for a very rare genetic disorder, but not for autism. On Tuesday, the U.S. agency said the drug helps children and adults who cannot get enough folate into ...

Colon cancer is appearing more often in younger adults, and many of those cases go undetected until the disease has already spread.

Pharmacy benefit managers (PBMs) have used market leverage to demand rebates, which can lead drug manufacturers to increase sticker prices.

Pharmacists have urged Wes Streeting to stockpile medicines that may run out because of Iran’s blockade on the Strait of ...

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and ...

Merck & Co., Inc. (NYSE:MRK) has been on a strong recovery run, gaining 23% over the past year and 8% year-to-date, though the stock has pulled back some, now well below its 52-week high of $125.14.

Paul Conyngham, an Australian technology enthusiast, developed a custom mRNA vaccine for his cancer-stricken dog, Rosie.

Salspera has set out plans for a $91 million IPO to fund the phase 3 study of its bacteria-based cancer therapy. | Salspera has set out plans for a $91 million IPO to fund the phase 3 study of its ...

In its preliminary guidance, NICE said it had concerns about the economic model proposed by Genmab to make the case for Tivdak's use by the NHS as a second-line therapy for cervical cancer, so it was ...

A large international study has mapped the genetic landscape of feline cancers for the first time, revealing striking similarities between tumor-driving mutations in cats, humans, and dogs.